- Home
- GNLN vs ALBT Comparison
GNLN vs ALBT Comparison
Compare GNLN & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLN
- ALBT
- Stock Information
- Founded
- GNLN 2005
- ALBT 2014
- Country
- GNLN United States
- ALBT United States
- Employees
- GNLN N/A
- ALBT N/A
- Industry
- GNLN Durable Goods
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GNLN Consumer Discretionary
- ALBT Health Care
- Exchange
- GNLN Nasdaq
- ALBT Nasdaq
- Market Cap
- GNLN 1.6M
- ALBT 7.9M
- IPO Year
- GNLN 2019
- ALBT N/A
- Fundamental
- Price
- GNLN $0.51
- ALBT $4.50
- Analyst Decision
- GNLN
- ALBT
- Analyst Count
- GNLN 0
- ALBT 0
- Target Price
- GNLN N/A
- ALBT N/A
- AVG Volume (30 Days)
- GNLN 325.8K
- ALBT 157.9K
- Earning Date
- GNLN 11-15-2024
- ALBT 04-14-2025
- Dividend Yield
- GNLN N/A
- ALBT N/A
- EPS Growth
- GNLN N/A
- ALBT N/A
- EPS
- GNLN N/A
- ALBT N/A
- Revenue
- GNLN $21,605,000.00
- ALBT N/A
- Revenue This Year
- GNLN $72.27
- ALBT N/A
- Revenue Next Year
- GNLN $93.46
- ALBT N/A
- P/E Ratio
- GNLN N/A
- ALBT N/A
- Revenue Growth
- GNLN N/A
- ALBT N/A
- 52 Week Low
- GNLN $0.48
- ALBT $2.11
- 52 Week High
- GNLN $21.80
- ALBT $21.60
- Technical
- Relative Strength Index (RSI)
- GNLN 18.13
- ALBT 43.56
- Support Level
- GNLN $0.51
- ALBT $4.60
- Resistance Level
- GNLN $0.58
- ALBT $11.60
- Average True Range (ATR)
- GNLN 0.06
- ALBT 1.86
- MACD
- GNLN 0.01
- ALBT -0.49
- Stochastic Oscillator
- GNLN 9.35
- ALBT 1.92
About GNLN Greenlane Holdings Inc.
Greenlane Holdings Inc is a distributor of vaporization products and consumption accessories in the United States. It offers a selection of stock-keeping units including vaporizers and parts, cleaning products, grinders and storage containers, pipes, rolling papers and customized lines of premium specialty packaging. The company markets and sells its products in both the business to business and business to consumer sectors of the marketplace. Its geographical segment includes the United States; Canada and Europe. It derives a majority of revenue from the United States.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.